Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
Leif Groop(Broad Institute), H Li(Lund University), Carol Forsblom(University of Helsinki), Michael J. Nissen(University Hospital of Geneva), Annelie Carlsson(Lund University), Börje Snickars(Lund University), Marja‐Riitta Taskinen(Hospital District of Helsinki and Uusimaa), Carola Saloranta(Lund University), Bo Isomaa(Lund University), Birgitta Ehrnström(Norwegian University of Science and Technology), Anna-Lena Nilsson(Lund University), Aaro Miettinen(Lund University), Kaj Lahti(Lund University), Björn Forsén(Lund University)
Cited by 509
Related Papers
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
|Nature Genetics|2003|10.6k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
|European Heart Journal|2013|2.7k
Lipoprotein(a) as a cardiovascular risk factor: current status
|European Heart Journal|2010|1.8k